XACT Robotics' Robotic-Driven Percutaneous Procedures

XACT Robotics' Robotic-Driven Percutaneous Procedures

MPO's Sean Fenske speaks with Chen Levin of XACT Robotics about a self-steering robot for ablation, biopsy, and drug delivery.

By Sean Fenske, Editor-in-Chief03.23.21
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Chen Levin, CEO of XACT Robotics. She offers insights on the capabilities of the XACT ACE Robotic System that enables a doctor to identify a target in the body and the robot to reach the target. The robot can make adjustments should the target move due to the movement of tissue during the procedure. The robot can be used for ablation, biopsy, or drug delivery. Specifically, the following questions are addressed.

  • Can you please briefly explain the current problem with trying to diagnose a suspicious tumor that’s too small or hard to reach?
  • How does the XACT ACE robot help with this challenge?
  • What type of vision system is being used by the robot to visualize the tissue?
  • How does the robot track the tissue even if it moves during the procedure?
  • How many of these are being implemented? How many of these are out on the market?
  • Are there other applications for this type of technology that are either in development or could see market soon?

Listen to this episode and see what you think of this robotic navigation technology. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Click here to review other podcasts.
Related Searches:
Suggested For You